Selexipag price information and recommendations for regular purchase channels

Selexipag tablets(Selexipag) is an innovative drug specially used to treatpulmonary arterial hypertension (PAH). Pulmonary hypertension is a serious cardiovascular disease. The patient's pulmonary artery blood pressure is abnormally elevated, resulting in increased heart burden. Symptoms such as dyspnea, fatigue, chest pain, and syncope may occur. In severe cases, it may even be life-threatening. Serepag tablets promote the relaxation of pulmonary arteries by activating prostacyclin receptors (IP receptors) in the body, thereby improving blood circulation, alleviating symptoms, delaying disease progression, and providing new treatment hope for patients.

Serepag tablets are oral tablets that are highly effective and long-acting. It can be metabolized into an active metabolite in the body, which selectively acts on prostacyclin receptors and exerts a vasodilatory effect. This mechanism of action makes selepag tablets highly effective in the treatment of pulmonary hypertension, which can significantly reduce patients' pulmonary artery pressure, improve heart function, and improve quality of life.

However, like other medications, selepag tablets may cause some side effects during use. These side effects may include headache, nausea, vomiting, diarrhea, muscle pain, and facial flushing. In addition, some patients may also experience symptoms such as allergic reactions or thyroid dysfunction. Therefore, during the use of selepag tablets, patients need to pay close attention to their body's reaction and conduct relevant examinations regularly to ensure the safety and effectiveness of the treatment.

The launch of Serepag tablets brings new treatment options to patients with pulmonary arterial hypertension. However, drug therapy is only one part of comprehensive treatment for pulmonary hypertension. Patients also need to combine other treatments, such as oxygen therapy, pulmonary rehabilitation training, etc., to comprehensively improve their condition. At the same time, maintaining good living habits and mentality are also important factors in the treatment of pulmonary hypertension.

Selepag tablets have been successfully launched in the country and have been included in the scope of medical insurance reimbursement. The specifications of Serepag tablets on the domestic market are 0.2 mg and 60 tablets, with the original price exceeding 3,000 yuan. For specific prices after medical insurance reimbursement, please consult the local medical insurance reimbursement department for detailed information. In addition, we learned that there are imitation versions of Serepag tablets available overseas, with a specification of 0.2mg and 10 tablets, and each box costs only 150 yuan. If patients have needs for this drug, they can consult Yaofenxiang’s medical consultant.

In short, selepag tablets, as a drug specially used to treat pulmonary arterial hypertension, have significant clinical value and significance. However, patients need to pay close attention to side effects and physical reactions during use to ensure the safety and effectiveness of the treatment.

Reference link:https://www.drugs.com/mtm/selexipag-oral-injection.html